Staying ahead of the technology curve means strengthening your competitive advantage. That is why we give you data-driven innovation insights into the BioTech industry. This time, you get to discover 5 hand-picked gene sequencing solutions.
Global Startup Heat Map highlights 5 Top Gene Sequencing Solutions out of 435
The insights of this data-driven analysis are derived from the Big Data & Artificial Intelligence-powered StartUs Insights Discovery Platform, covering 1.379.000+ startups & scaleups globally. The platform gives you an exhaustive overview of emerging technologies & relevant startups within a specific field in just a few clicks.
The Global Startup Heat Map below reveals the distribution of the 435 exemplary startups & scaleups we analyzed for this research. Further, it highlights 5 BioTech startups that we hand-picked based on criteria such as founding year, location, funding raised, and more. You get to explore the solutions of these 5 startups & scaleups in this report. For insights on the other 430 gene sequencing solutions, get in touch.
Click to download
BioSkryb Genomics offers Whole Genome Amplification (WGA) Technology
Gene amplification gives rise to karyotype abnormalities such as double minutes (DM) and homogeneously staining regions (HSR). Both of these are indicated in human tumors and play a major role during embryonic development. To this end, startups and scaleups develop WGA technologies to cater to a wide range of applications, including drug discovery and clinical genomics.
The US-based startup BioSkryb Genomics develops ResolveDNA, a primary template-directed amplification (PTA) technology, to amplify individual genomes for downstream genetic analysis. It offers single-cell resolution and enables accurate variant analysis of single cells and sub-nanogram samples, as well as helps detect and characterize minimal residual disease (MRD). The startup’s technology supports single-cell and ultra-low input applications that include oncology, cardiology, immunology, microbiome research, and preimplantation genetic testing.
Genesy builds a Genomic Blockchain Platform
There are privacy and security concerns around human genomic data. Blockchain technology offers security and ensures that sequencing data is updated and available for doctors when prescribing treatment solutions. BioTech startups are developing blockchain solutions to store and access gene sequencing data.
Italian startup Genesy builds a genomic blockchain platform for storing personal DNA and microbiome sequencing data. The startup’s low-cost saliva kit enables users to provide their DNA sample seamlessly, after which the startup sequences the DNA and stores the data on a private blockchain platform. It uses big data to process the DNA test results and allow secure, instant access to the data.
GenomSys creates a Genomic Mobile App
Ease of access to personal DNA profiles enables users to leverage this data in case of any medical need. Further, simple tests for medication compatibility enable medical professionals to help patients with precision and accuracy. Startups develop smartphone applications that compress and store DNA sequences.
Swiss startup GenomSys provides a mobile application to store and view genomic data. The startup’s Genome App enables users to ask for gene sequencing and stores the results for later use. Moreover, Genomsys’s data format, MPEG-G, is secure and private ensuring improved data security. Further, the application assists users to compare medication against their DNA profile to check for compatibility.
OmiCure offers an Oncology Treatment Selection System
Startups leverage genomic information to create personalized plans for disease treatment. Moreover, genotyping cancer cells to understand what genes are dysregulated allows physicians to select the optimal chemotherapeutic solution and potentially limit the patient’s exposure to toxic treatments considering the therapy is personalized.
French startup OmiCure offers a gene sequencing-based oncology treatment selection system for cancer patients. The startup performs whole exome or transcriptome sequencing to identify changes in gene expression implicated in cancer development. Further, the startup leverages artificial intelligence (AI) to compare the tumor’s genomic information with a comprehensive knowledge base of clinical trials, approved medicines, literature reviews, and medical expertise. This enables medical professionals to suggest personalized treatment plans for cancer patients
Lumminary offers Whole Genome Sequencing
The costs of whole-genome sequencing are falling rapidly. In addition to BioTech advances, this is possible due to the sheer access to computing power required to sequence billions of individual nucleotides. Startups develop whole genome sequencing solutions to create extensive genome databases for applications in healthcare and agriculture.
British startup Lumminary offers whole genome sequencing solutions. The users receive a DNA collection kit with simple instructions and send it back to the startup. In three simple steps, the startup analyzes the entire human genome with a 15 fold multiplication to ensure accuracy in results. Luminary analyzes the sequence information to prepare a digital blueprint that defines every characteristic of a person, including height, weight, the color of eyes, and aging.
Discover more BioTech startups
BioTech startups such as the examples highlighted in this report focus on human genomics, gene editing, and bioinformatics. While all of these technologies play a major role in advancing BioTech, they only represent the tip of the iceberg. To explore more space technologies, simply get in touch to let us look into your areas of interest. For a more general overview, you can download our free BioTech Innovation Report to save your time and improve strategic decision-making.
